Considering that NEC intestinal injury requires NLRP3 inflammasome activation and IL-1β release, next, we determined to investigate whether MCC950, a specific small molecular inhibitor of NLRP3, could protect against intestinal inflammatory damage in experimental NEC mouse model. This evidence concerns the gene IL1B and necrotizing enterocolitis.